TABLE 3.
The Frequency of Grade 3–4 Treatment-Related Toxicities in 36 Patients With Invasive Anal Cancer Expressed as the Worst Toxicity Per Patient*
Type of Toxicity | HIV Positive (N = 13) |
HIV Negative (N = 23) |
---|---|---|
Neutropenia | ||
Grade 3 | 2 (15%) | 3 (13%) |
Thrombocytopenia | ||
Grade 3 | 1 (8%) | 1 (4%) |
Anemia | ||
Grade 3 | 2 (15%) | 1 (4%) |
Dermatitis | ||
Grade 3 | 3 (23%) | 12 (52%) |
Grade 4 | 0 | 1 (4%) |
Mucositis | ||
Grade 3 | 0 | 1 (4%) |
Infection | ||
Grade 3 | 1 (8%) | 2 (9%) |
Dehydration | ||
Grade 3 | 2 (15%) | 2 (9%) |
Diarrhea | ||
Grade 3 | 2 (15%) | 3 (13%) |
Nausea | ||
Grade 3 | 0 | 1 (4%) |
Vomiting | ||
Grade 3 | 0 | 1 (4%) |
Encephalopathy | ||
Grade 4 | 1 (8%) | 0 |
Toxicity data was not available on 9 patients in the HIV-negative group.